According to Moderna 's latest financial reports the company's total assets are $18.42 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $18.42 B | -28.74% |
2022-12-31 | $25.85 B | 4.82% |
2021-12-31 | $24.66 B | 236.23% |
2020-12-31 | $7.33 B | 361.61% |
2019-12-31 | $1.58 B | -19% |
2018-12-31 | $1.96 B | 80.93% |
2017-12-31 | $1.08 B | -23.47% |
2016-12-31 | $1.41 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $167.55 B | 809.36% | ๐บ๐ธ USA |
Novartis NVS | $94.33 B | 411.96% | ๐จ๐ญ Switzerland |
Merck MRK | $106.67 B | 478.94% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | $30.75 M | -99.83% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | N/A | N/A | ๐บ๐ธ USA |
Athersys ATHX | $7.42 M | -99.96% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.82 B | -79.21% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $0.62 B | -96.60% | ๐บ๐ธ USA |